Viewing StudyNCT00273884



Ignite Creation Date: 2024-05-05 @ 4:36 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00273884
Status: COMPLETED
Last Update Posted: 2007-02-19
First Post: 2006-01-05

Brief Title: Amonafide in Combination With Cytarabine in Secondary AML
Sponsor: Xanthus Pharmaceuticals Inc
Organization: Xanthus Pharmaceuticals Inc

Conditions & Keywords Data

Conditions:
Name
Acute Myeloid Leukemia
Keywords:
Name View
Leukemia View
AML View
Secondary AML View